Plantar Fasciitis Treatment: Shockwave, PRP, and the Path Out of Heel Pain

Plantar fasciitis is one of the most common foot complaints in adults and one of the most frustrating to live with. The classic morning-pain pattern is unmistakable: those first steps out of bed feel like stepping on glass. The pain typically eases as the foot warms up, then returns after prolonged sitting or at the end of a long day on your feet.

For acute cases, conservative care often works. For chronic cases (6+ months of symptoms), active intervention shortens what can otherwise be a multi-year ordeal. This guide covers what works, what doesn't, and what to expect.

What plantar fasciitis actually is

The plantar fascia is a thick band of connective tissue that runs from the heel bone (calcaneus) along the bottom of the foot to the base of the toes. It supports the arch and absorbs ground reaction forces during walking and running.

The condition called plantar fasciitis involves degenerative changes at the proximal plantar fascia attachment on the calcaneus. Despite the "-itis" suffix, histologic studies (Lemont 2003 and others) show that the underlying problem is degenerative rather than purely inflammatory: disorganized collagen, microscopic tearing, abnormal blood vessel ingrowth, similar in character to the tendinopathies we see elsewhere.

The contemporary term "plantar fasciopathy" or "plantar fasciosis" is more anatomically accurate. Most clinicians still use "plantar fasciitis" because it's what patients have heard.

The "heel spur" found on X-ray in many plantar fasciitis patients is a separate finding that often coexists with the condition. The spur itself is rarely the source of pain; it's a marker of chronic stress at the fascia origin. Surgical removal of heel spurs in isolation does not reliably relieve plantar fasciitis.

How it typically presents

Pain at the bottom of the heel, often radiating along the arch. Worst with first steps in the morning ("post-static dyskinesia"), eased by gentle walking, recurring after prolonged sitting or standing. Often unilateral but can be bilateral.

The exam reveals tenderness at the medial plantar calcaneal tuberosity (the underside of the heel, slightly toward the inner edge). Range of motion in the ankle is sometimes reduced. Calf tightness is commonly present and contributes mechanically. The Windlass test (passive dorsiflexion of the great toe) often reproduces the pain.

Imaging is typically not required for diagnosis. Ultrasound or MRI can confirm fascia thickening (>4 mm at the calcaneal attachment is supportive) and rule out other causes when the presentation is atypical.

Differential diagnosis worth keeping in mind

Not all heel pain is plantar fasciitis. Worth ruling out:

Calcaneal stress fracture. Often diffuse heel pain, worse with weight bearing across the whole heel rather than focal at the medial tuberosity. Imaging confirms.

Fat pad atrophy. Loss of the protective heel fat pad, common in older adults. Pain is more diffuse, often related to direct loading rather than to specific maneuvers.

Tarsal tunnel syndrome. Compression of the posterior tibial nerve at the inner ankle. Often involves burning, tingling, or paresthesias rather than mechanical pain.

Baxter's nerve entrapment. Compression of the first branch of the lateral plantar nerve, can mimic plantar fasciitis.

Rheumatologic causes. Particularly seronegative spondyloarthropathies (ankylosing spondylitis, reactive arthritis, psoriatic arthritis) can cause enthesitis at the plantar fascia origin.

Plantar fibroma. Benign nodular thickening within the plantar fascia, more distal than typical plantar fasciitis.

We work through this differential during the consultation. Most cases are straightforward; some require additional workup.

The conservative care pathway

For acute and early chronic cases, conservative care should be tried fully before injection-based intervention:

Activity modification. Reducing the time spent on hard surfaces, reducing running volume if applicable.

Stretching. Calf stretching (gastrocnemius and soleus separately), plantar fascia stretching (towel stretch or specific plantar fascia-specific stretching protocol).

Footwear. Supportive shoes with good arch support, avoiding barefoot walking on hard surfaces.

Orthotics. Over-the-counter or custom arch supports. The evidence for custom over OTC is mixed; OTC is a reasonable first try.

Night splints. Hold the foot in dorsiflexion overnight to keep the plantar fascia from contracting. Particularly helpful for the morning pain pattern.

Manual therapy and PT. A structured PT program targeting calf flexibility, foot intrinsic strength, and lower limb mechanics often produces meaningful improvement.

NSAIDs. Short-term for symptom control.

For most patients, this combination produces meaningful improvement over 8 to 12 weeks. Patients who haven't improved by 12 to 16 weeks of consistent conservative care are reasonable candidates for active intervention.

Why we usually avoid cortisone in chronic plantar fasciitis

Corticosteroid injection into the plantar fascia origin provides rapid symptomatic relief (often within days) but has significant downsides:

Plantar fascia rupture risk. Published case series document plantar fascia rupture rates of 2 to 10 percent after corticosteroid injection, with rupture risk increasing with each subsequent injection. Plantar fascia rupture changes the foot mechanics and can produce persistent pain that's harder to manage than the original fasciitis.

Heel fat pad atrophy. Repeated steroid injections can thin the protective heel fat pad, producing a different kind of chronic heel pain.

Limited long-term effect. The relief from a single cortisone injection typically lasts 4 to 12 weeks, then symptoms recur. The pattern of repeated injections with diminishing returns is similar to what we see in other tendinopathies.

A single cortisone injection in a specific scenario (severe pain limiting activity in the short term, with a clear short-term goal) can be reasonable. For chronic management, the math doesn't favor cortisone.

Shockwave for plantar fasciitis

Plantar fasciitis is the original FDA-cleared indication for orthopedic shockwave (cleared in 2000) and has one of the most consistent evidence bases in musculoskeletal medicine.

Mechanism. Shockwave delivers brief acoustic pulses that cause mechanotransduction in the affected tissue, stimulating local vascularity, recruiting growth factor signaling, and supporting tendon remodeling. (More in our shockwave guide.)

Protocol. Typical course is 4 to 6 sessions, spaced 5 to 10 days apart. Each session runs 8 to 15 minutes. No anesthesia required. Patient drives home and returns to normal activity immediately after.

Patient experience. A brisk tapping sensation through the heel, uncomfortable but not painful. Some patients have local soreness or mild bruising for 1 to 3 days after each session.

Expected response. Symptomatic improvement typically begins 2 to 4 weeks after starting the course and continues for several weeks after the final session as the tissue remodeling catches up. 60 to 80 percent of patients show meaningful improvement at 12 to 16 weeks. Effect typically durable for 12+ months.

Evidence base. Multiple RCTs and systematic reviews supporting effectiveness in chronic plantar fasciitis, particularly cases that have failed conservative care.

When shockwave isn't enough. A subset of patients have partial or incomplete response. For these patients, PRP is often the appropriate next step, either after the shockwave course or in combination.

PRP for plantar fasciitis

PRP delivers concentrated growth factors directly into the affected plantar fascia tissue.

Protocol. Single injection (sometimes a second at 6 to 8 weeks for incomplete response). Ultrasound-guided, with the needle visualized in the affected fascia tissue. Leukocyte-rich PRP at concentration appropriate for tendon/fascia work. Often fenestration technique to maximize PRP distribution and provoke a controlled mechanical response.

Patient experience. Local anesthetic for comfort. The procedure itself is brief (5 to 10 minutes of needle time). Some patients experience a brief inflammatory flare in the first 24 to 72 hours, expected and self-limited.

Activity restriction. Limited weight-bearing for 24 to 72 hours, no high-impact activity for 4 to 6 weeks.

Expected response. Improvement typically begins at 4 to 6 weeks, with continued improvement through 12 to 16 weeks. 60 to 75 percent of patients show meaningful improvement at 12 weeks.

Evidence base. Multiple RCTs comparing PRP to corticosteroid and to placebo. PRP consistently outperforms corticosteroid at 6 and 12 months in pooled data, without the rupture risk and fat pad atrophy concerns of repeated steroid use.

Combining shockwave and PRP

For severe, recalcitrant cases, we sometimes sequence the two: a shockwave course (4 to 6 sessions over 4 to 6 weeks) followed by a single PRP injection. The biological logic is that shockwave primes the tissue, increases vascularity, and recruits cellular machinery for repair, after which PRP delivers a high-dose growth factor payload that the primed tissue can use.

Combination protocols are not always necessary. For most patients, one modality alone is sufficient. We reserve the combination for cases where the disease is severe, longstanding, or has failed prior single-modality treatment.

What recovery looks like

For a shockwave-first protocol:

Weeks 1 to 4 (treatment phase). Brief sessions every 5 to 10 days. Normal daily activity throughout, with sensible reduction in high-impact loading. Mild local soreness after each session.

Weeks 4 to 8 (early response phase). First signs of symptomatic improvement. Continued PT, stretching, and conservative care alongside.

Weeks 8 to 16 (consolidation phase). Continued improvement. Most responders are clearly better by week 12 to 16.

Months 4 to 12 (durability phase). Effect typically persists. Re-evaluation if symptoms recur.

For a PRP-first protocol:

Days 1 to 7. Limited weight-bearing initially, sometimes pronounced soreness. Activity modifications.

Weeks 2 to 4. Return to most normal activity. Continued conservative care.

Weeks 4 to 6. Beginning of symptomatic improvement.

Weeks 8 to 12. Clear improvement in responders.

Months 3 to 6. Peak effect.

What you can do alongside treatment

Regardless of which active intervention you choose, certain things help:

Calf flexibility. Soleus and gastrocnemius stretching, daily. Tight calves contribute to plantar fascia load.

Plantar fascia-specific stretching. Towel stretches, tennis ball rolling under the foot, dedicated stretching protocols.

Supportive footwear. Particularly important in the recovery period. Minimal/barefoot shoes are generally not the right choice during active recovery.

Night splints. Particularly helpful for the morning pain pattern.

Foot intrinsic strengthening. Toe spreading, towel scrunches, short-foot exercises.

Address biomechanical contributors. Overuse, weight changes, footwear changes, surface changes (concrete vs grass) all contribute. Identify and modify what you can.

When to consider surgery

Surgery for plantar fasciitis (plantar fascia release, with or without other procedures) is reserved for severe refractory cases that have failed:

• 12+ months of conservative care
• A full shockwave course
• A PRP series
• Address of biomechanical contributors

Surgical recovery is 6 to 12 weeks of restricted weight-bearing followed by gradual return to activity. Outcomes are mixed; some patients do very well, others have persistent symptoms or new mechanical issues from the release. Most patients who reach surgical consideration have very chronic, very refractory cases.

Specific patient profiles

The 45-year-old recreational runner with 6 months of right heel pain. Conservative care plus PT first if not yet tried. If failed, shockwave course. PRP if shockwave is incomplete.

The 58-year-old teacher with chronic bilateral plantar fasciitis after a career standing on hard floors. Bilateral shockwave course. Address footwear and standing-time management. PRP if incomplete response on one or both sides.

The 35-year-old new mother who developed plantar fasciitis after pregnancy weight gain. Conservative care with attention to footwear, weight, and biomechanics. Shockwave if persistent.

The 62-year-old marathon runner who's had three prior cortisone shots and now has new diffuse heel pain. Concern for fat pad atrophy and/or plantar fascia rupture. Imaging to assess. Different management depending on findings.

The 28-year-old with sudden severe heel pain after a misstep. Concern for acute plantar fascia rupture or calcaneal stress fracture. Imaging first, then treatment specific to findings.

How to book

To request a consultation about your heel pain, request a consultation or call (972) 768-2328. We're at 2111 Kirkwood Blvd, Suite 110b, Southlake, TX 76092.

If you've had multiple cortisone shots and your symptoms are worsening or your foot feels different, come in for an evaluation before the next intervention.

A short note from Dr. Abdullah

Plantar fasciitis is one of those conditions where most patients have been told "wait it out" and a meaningful percentage of them have been waiting for years. The conservative care pathway is real and works for many people, but the patient who's still suffering at 6+ months deserves an active intervention. Shockwave is the boring, evidence-supported, often-overlooked first answer. PRP is the layered next step. Most patients we treat with this combination are walking comfortably for the first time in a long time within 3 to 4 months. That's a good win for relatively low-intensity intervention.